Random forests to predict survival of octogenarians with brain metastases from nonsmall-cell lung cancer

被引:0
|
作者
Lijun Song [1 ]
Yu Wang [2 ]
Xue Li [3 ]
Yi Liu [3 ]
Bingyi Yin [3 ]
Daorui Li [3 ]
Hongsheng Lin [3 ]
Yuqi Zhang [1 ]
机构
[1] Department of Neurosurgery, Yuquan Hospital, Tsinghua University
[2] Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University
[3] Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences
关键词
D O I
暂无
中图分类号
R734.2 [肺肿瘤]; TP181 [自动推理、机器学习];
学科分类号
摘要
Background: To create and validate nomograms for the personalized prediction of survival in octogenarians with newly diagnosed nonsmall-cell lung cancer(NSCLC) with sole brain metastases(BMs). Methods: Random forests(RF) were applied to identify independent prognostic factors for building nomogram models. The predictive accuracy of the model was evaluated based on the receiver operating characteristic(ROC) curve, C-index, and calibration plots. Results: The area under the curve(AUC) values for overall survival at 6, 12, and 18 months in the validation cohort were 0.837, 0.867, and 0.849, respectively; the AUC values for cancer-specific survival prediction were 0.819, 0.835, and 0.818, respectively. The calibration curves visualized the accuracy of the model. Conclusion: The new nomograms have good predictive power for survival among octogenarians with sole BMs related to NSCLC.
引用
收藏
页码:39 / 56
页数:18
相关论文
共 50 条
  • [2] Metachronous brain and intramedullary spinal cord metastases from nonsmall-cell lung cancer: A case report
    Liu, Wen-Chih
    Chung, Chia-Li
    Chai, Chee-Yin
    Tan, Lia-Beng
    Wang, Chih-Jen
    Kwan, Aij-Lie
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2012, 28 (05): : 289 - 293
  • [3] Immunotherapy for nonsmall-cell lung cancer
    Belalcazar, Astrid
    Raez, Luis E.
    Santos, Edgardo S.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2012, 5 (02) : 90 - 93
  • [4] Immunotherapy for nonsmall-cell lung cancer
    Astrid Belalcazar
    Luis E. Raez
    Edgardo S. Santos
    memo - Magazine of European Medical Oncology, 2012, 5 (2) : 90 - 93
  • [5] Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer?
    Cistaro, Angelina
    Quartuccio, Natale
    Mojtahedi, Alireza
    Fania, Piercarlo
    Filosso, Pier Luigi
    Cucinotta, Mariapaola
    Campenni, Alfredo
    Ficola, Umberto
    Baldari, Sergio
    SCIENTIFIC WORLD JOURNAL, 2013,
  • [6] Pulmonary resection in patients with nonsmall-cell lung cancer treated with gamma-knife radiosurgery for synchronous brain metastases
    Yang, Seung-Yeob
    Kim, Dong Gyu
    Lee, Se-Hoon
    Chung, Hyun-Tai
    Paek, Sun Ha
    Kim, Joo Hyun
    Jung, Hee-Won
    Han, Dae Hee
    CANCER, 2008, 112 (08) : 1780 - 1786
  • [7] HYDRAZINE SULFATE IN NONSMALL-CELL LUNG-CANCER
    GOLD, J
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) : 1117 - 1118
  • [8] Is major pathologic response sufficient to predict survival in resectable nonsmall-cell lung cancer patients receiving neoadjuvant chemotherapy?
    Cai, Jing-Sheng
    Li, Shuo
    Yan, Shu-Mei
    Yang, Jie
    Yang, Mu-Zi
    Xie, Chu-Long
    Li, Ji-Bin
    Feng, Yan-Fen
    Yang, Hao-Xian
    Hou, Xue
    THORACIC CANCER, 2021, 12 (09) : 1336 - 1346
  • [9] Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancer
    De Pauw, Rebecca
    van Meerbeeck, Jan P.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (02) : 92 - 97
  • [10] The Mediastinoscopy and the Future in Nonsmall-Cell Lung Cancer Staging
    Nosotti, Mario
    De Simone, Matilde
    Cioffi, Ugo
    THORACIC AND CARDIOVASCULAR SURGEON, 2012, 60 (02): : 122 - 123